Test Code LAB3266 Ustekinumab Quantitation with Antibodies, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL Serum
Collection Instructions:
1. Draw blood immediately before the next dose of drug administration (trough level).
2. Centrifuge and aliquot serum into a plastic vial.
Forms
If not ordering electronically, complete, print, and send 1 of the following with the specimen:
-Gastroenterology and Hepatology Test Request (T728)
-Therapeutics Test Request (T831)
Useful For
Evaluating patients for loss of response, partial response on initiation of therapy, autoimmune or hypersensitivity reactions, primary nonresponse, reintroduction after drug holiday, endoscopic/computed tomography enterography recurrence (in inflammatory bowel disease) and acute infusion reactions using trough level specimens
This test does not differentiate between the originator and biosimilar products.
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| USQN | Ustekinumab QN, S | No | Yes |
| USTAB | Ustekinumab Ab, S | No | Yes |
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name
Ustekinumab QN with Antibodies, SSpecimen Type
SerumSpecimen Minimum Volume
Serum: 0.35 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 21 days |
| Frozen | 21 days |
Reference Values
USTEKINUMAB QUANTITATION:
Limit of quantitation is 0.3 mcg/mL
For maintenance stages:
Concentrations ≥1.0 mcg/mL are associated with clinical response and clinical remission
Concentrations ≥4.5 mcg/mL are associated with mucosal healing
USTEKINUMAB ANTIBODIES:
Limit of quantitation is 10 AU/mL
Absent: <10 AU/mL
Present: ≥10 AU/mL
Day(s) Performed
Monday, Wednesday, Friday
Report Available
2 to 5 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80299
83520
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| USTEK | Ustekinumab QN with Antibodies, S | In Process |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| USQN | Ustekinumab QN, S | 87408-1 |
| USTAB | Ustekinumab Ab, S | 87409-9 |
Testing Algorithm
For information see Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm.
Special Instructions
Call Laboratory Medicine resident at digital pager 314-747-1320 for approval before drawing the specimen.